scorecardresearch
Add as a preferred source on Google
Friday, November 21, 2025
TopicCholesterol drugs

Topic: cholesterol drugs

Demand soars for twice-a-year jab to lower bad cholesterol. Here’s how it works

Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Does egg consumption lead to diabetes? A new study claimed so but here’s the full picture

Eggs are one of the most nutritious foods providing best quality protein, all essential amino acids, vitamins, and minerals. This high-protein food is a must in low-carb diets.

Higher apolipoprotein B shortens lifespan, increases risk of heart disease, finds Lancet study

The study says apolipoprotein B, a protein involved in the metabolism of lipids, contributes to formation of fatty acid deposits on arteries which may result in heart disease.

Hospitalised Covid patients on some cholesterol drugs half as likely to die, finds study

Statins are commonly given to cholesterol patients & help lower risk of cardiovascular disease. Studies show it likely reduces mortality in hospitalised Covid cases, experts call for trials.

Cholesterol drugs could reduce risk of lethal prostate cancer in men by 24%, study says

According to the study, statins reduce the risk of developing a lethal form of the disease but they do not affect the overall rates of prostate cancer in men.

On Camera

Hasina’s was a trial in absentia, but not a trial without justice

The Sheikh Hasina trial represents an inflection point in the struggle to place citizens above rulers and prevent the next massacre.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Can’t stay behind tech curve anymore, must catch up—Vice Chief of Navy Staff ahead of Swavlamban 2025

New Delhi: Noting that India cannot afford to stay behind the technology curve when it comes to war-fighting, Vice Chief of the Naval Staff...

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.